Recently, Cyberonics announced that it had reached a milestone with its Vagus Nerve Stimulation Therapy unit (VNS). The company said the device has reached 100,000 units to be implanted in epileptic patients. This milestone was reached after the device has been on the market for 15 years.
This milestone of usage also shows that the VNS system has been accepted as a treatment for refractory epilepsy. Clinical studies that were conducted by researchers at New York University have proven that the VNS system works in treating refractory epilepsy, and that it even was able to lessen the event of seizures by 50 percent in as many as 60 percent of the patients given the implant.
Epilepsy is a common condition that is suffered by millions of people worldwide. Epilepsy research has long been focused on finding a safe and effective treatment to prevent seizures. For now, the majority of patients are being treated with various prescription medications — ones that can often post dangerous side effects that are worse than the condition the drug is used to treat. One of those medications is Topamax. Topamax has been linked to babies being born with birth defects, including PPHN, oral clefts, spina bifida and neural tube defects when the mothers take the pills while pregnant. Topamax use is often dangerous because doctors have to guess which dosage to use on patients in order to find the right one.
That guess-work also has doctors trying out various other prescription medications that are just as dangerous as Topamax when looking for the right drug and dosage to treat their patients. This trial and error is overwhelming to the many patients looking for seizure relief.
If your baby has suffered from birth defects after being exposed to Topamax in-utero, contact attorney Greg Jones today for a free consultation. I am experienced at fighting Topamax lawsuits and may be able to help you recover money for your child’s injury.
About Greg Jones Law
You May Also Like